6BOF

Crystal structure of KRAS A146T-GDP demonstrating open switch 1 conformation

Summary for 6BOF

• Entry DOI: 10.2210/pdb6bof/pdb
• Descriptor: GTPase KRas, GUANOSINE-5'-DIPHOSPHATE (3 entities in total)
• Functional Keywords: hydrolase, small gtpase, signal transduction, gdp binding
• Biological source: Homo sapiens (Human)
• Total number of polymer chains: 2
• Total formula weight: 39227.58

Authors

Bera, A.K.,Yan, W.,Westover, K.D. (deposition date: 2017-11-20, release date: 2019-05-22, Last modification date: 2023-10-04)

Primary citation

Poulin, E.J.,Bera, A.K.,Lu, J.,Lin, Y.J.,Strasser, S.D.,Paulo, J.A.,Huang, T.Q.,Morales, C.,Yan, W.,Cook, J.,Nowak, J.A.,Brubaker, D.K.,Joughin, B.A.,Johnson, C.W.,DeStefanis, R.A.,Ghazi, P.C.,Gondi, S.,Wales, T.E.,Iacob, R.E.,Bogdanova, L.,Gierut, J.J.,Li, Y.,Engen, J.R.,Perez-Mancera, P.A.,Braun, B.S.,Gygi, S.P.,Lauffenburger, D.A.,Westover, K.D.,Haigis, K.M.
Tissue-Specific Oncogenic Activity of KRASA146T.
Cancer Discov, 9:738-755, 2019

PubMed Abstract: is the most frequently mutated oncogene. The incidence of specific alleles varies between cancers from different sites, but it is unclear whether allelic selection results from biological selection for specific mutant KRAS proteins. We used a cross-disciplinary approach to compare KRAS, a common mutant form, and KRAS, a mutant that occurs only in selected cancers. Biochemical and structural studies demonstrated that KRAS exhibits a marked extension of switch 1 away from the protein body and nucleotide binding site, which activates KRAS by promoting a high rate of intrinsic and guanine nucleotide exchange factor-induced nucleotide exchange. Using mice genetically engineered to express either allele, we found that KRAS and KRAS exhibit distinct tissue-specific effects on homeostasis that mirror mutational frequencies in human cancers. These tissue-specific phenotypes result from allele-specific signaling properties, demonstrating that context-dependent variations in signaling downstream of different KRAS mutants drive the mutational pattern seen in cancer. SIGNIFICANCE: Although epidemiologic and clinical studies have suggested allele-specific behaviors for , experimental evidence for allele-specific biological properties is limited. We combined structural biology, mass spectrometry, and mouse modeling to demonstrate that the selection for specific KRAS mutants in human cancers from different tissues is due to their distinct signaling properties...

PubMed: 30952657
DOI: 10.1158/2159-8290.CD-18-1220

Experimental method

X-RAY DIFFRACTION (1.401 Å)